Drug profile · INN
aminolevulinic acid hydrochloride
ALABEL/ALAGLIO
aminolevulinic acid hydrochloride (ALABEL/ALAGLIO) is a dna inhibitor. Route of administration: topical. Current US regulatory status: approved.
Drug details — aminolevulinic acid hydrochloride
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
aminolevulinic acid hydrochloride (ALABEL/ALAGLIO) is a dna inhibitor. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is aminolevulinic acid hydrochloride?
aminolevulinic acid hydrochloride (ALABEL/ALAGLIO) is a dna inhibitor. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for aminolevulinic acid hydrochloride?
ALABEL/ALAGLIO is a marketed brand name for aminolevulinic acid hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of aminolevulinic acid hydrochloride?
aminolevulinic acid hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.